Editorial Commentary:Association of Comorbid Asthma and the Efficacy of Bioabsorbable Steroid-eluting Sinus Stents Implanted after Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polyps
作者机构:Department of Otolaryngology-Head and Neck SurgeryThe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou510630China Department of AllergyThe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou510630China Naso-Orbital-Maxilla and Skull Base CenterThe Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou510630China
出 版 物:《Current Medical Science》 (当代医学科学(英文))
年 卷 期:2023年第43卷第6期
页 面:1258-1259页
核心收录:
学科分类:1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 10[医学]
主 题:Surgery operative treatment
摘 要:Chronic rhinosinusitis with nasal polyps(CRSw-NP)is a multifactorial and heterogeneous disorder of the sinonasal mucosa,characterized by a high relapse rate after medical and surgical treatments[1].Endoscopic sinus surgery(ESS)is the preferred treatment for CRSwNP in patients who have failed to respond to medical therapy[2].However,the postoperative complications will impair the recovery of patients,and accompanying post-operative outpatient visits may contribute to patient discomfort[3]Suppressing postoperative mucosa edema and improving mucosa recovery is critical to reducing the disease relapse after ESS.The steroid-eluting sinus stent(SESS)represents a promising emerging therapy for CRSwNP.